MeSH term
Frequency | Condition_Probility | Animals | 107 | 0.0 |
Apoptosis/*immunology | 3 | 1.0 |
Humans | 253 | 0.0 |
Signal Transduction/*immunology | 5 | 1.0 |
Amino Acid Sequence | 68 | 0.0 |
Base Sequence | 21 | 0.0 |
Cloning, Molecular | 25 | 0.0 |
DNA Primers | 8 | 0.0 |
Electrophoretic Mobility Shift Assay | 4 | 0.0 |
Enzyme Activation | 51 | 1.0 |
Interleukin-1/*physiology | 5 | 5.0 |
Molecular Sequence Data | 71 | 0.0 |
Protein-Serine-Threonine Kinases/metabolism | 19 | 2.0 |
Proteins/chemistry/genetics/*physiology | 2 | 15.0 |
Research Support, Non-U.S. Gov't | 175 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 22 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 7 | 0.0 |
Tumor Necrosis Factor-alpha/*physiology | 13 | 4.0 |
*Apoptosis | 16 | 1.0 |
Cattle | 2 | 0.0 |
Cells, Cultured | 29 | 0.0 |
Hydrogen Peroxide/pharmacology | 3 | 1.0 |
MAP Kinase Kinase Kinase 5 | 5 | 21.0 |
MAP Kinase Kinase Kinases/*metabolism | 4 | 11.0 |
Models, Biological | 20 | 0.0 |
Mutation | 26 | 0.0 |
Proteins/physiology | 7 | 4.0 |
Research Support, U.S. Gov't, P.H.S. | 96 | 0.0 |
TNF Receptor-Associated Factor 2 | 169 | 82.0 |
Tumor Necrosis Factor-alpha/pharmacology | 16 | 1.0 |
Antigens, CD30/genetics/metabolism | 2 | 66.0 |
Hela Cells | 31 | 0.0 |
Membrane Glycoproteins/genetics/metabolism | 2 | 2.0 |
Proteins/genetics/metabolism | 5 | 2.0 |
Receptors, Tumor Necrosis Factor/genetics/*metabolism | 9 | 25.0 |
Receptors, Tumor Necrosis Factor, Type I | 29 | 9.0 |
Receptors, Tumor Necrosis Factor, Type II | 17 | 7.0 |
TNF Receptor-Associated Factor 1 | 76 | 49.0 |
Tumor Necrosis Factor-alpha/genetics/*metabolism | 4 | 7.0 |
Apoptosis | 22 | 1.0 |
Blotting, Northern | 4 | 0.0 |
Cell Death | 5 | 1.0 |
Cell Line | 106 | 0.0 |
Dose-Response Relationship, Drug | 15 | 0.0 |
Fibroblasts/metabolism | 4 | 0.0 |
Gene Library | 3 | 0.0 |
Genes, Reporter | 15 | 0.0 |
Mice | 68 | 0.0 |
Models, Genetic | 4 | 0.0 |
Plasmids/metabolism | 11 | 0.0 |
Protein Binding | 57 | 0.0 |
Protein Structure, Tertiary | 28 | 0.0 |
Sequence Homology, Amino Acid | 27 | 0.0 |
Time Factors | 20 | 0.0 |
Tissue Distribution | 5 | 0.0 |
Trans-Activation (Genetics) | 9 | 0.0 |
*Transcription, Genetic | 7 | 0.0 |
Transfection | 64 | 0.0 |
Tumor Necrosis Factor-alpha/*metabolism | 16 | 2.0 |
*Adaptor Proteins, Signal Transducing | 28 | 2.0 |
Binding Sites | 40 | 0.0 |
Crystallography, X-Ray | 4 | 0.0 |
Models, Molecular | 8 | 0.0 |
Point Mutation | 2 | 0.0 |
Proteins/*chemistry/genetics/*metabolism | 2 | 7.0 |
Signal Transduction/physiology | 12 | 1.0 |
TNF Receptor-Associated Factor 3 | 33 | 48.0 |
Cytoplasm/metabolism | 10 | 1.0 |
Gene Expression Regulation | 13 | 0.0 |
HL-60 Cells | 2 | 0.0 |
I-kappa B/metabolism | 4 | 5.0 |
Immunohistochemistry | 5 | 0.0 |
Jurkat Cells | 18 | 1.0 |
K562 Cells | 2 | 0.0 |
Microscopy, Confocal | 5 | 0.0 |
NF-kappa B/genetics/metabolism | 2 | 3.0 |
Proteins/*metabolism | 37 | 4.0 |
Receptors, Tumor Necrosis Factor/metabolism | 22 | 11.0 |
Signal Transduction | 66 | 1.0 |
Solubility | 2 | 0.0 |
TNF Receptor-Associated Factor 5 | 20 | 60.0 |
Tumor Cells, Cultured | 40 | 0.0 |
U937 Cells | 9 | 2.0 |
Fibroblasts | 2 | 0.0 |
TNF Receptor-Associated Factor 2/*metabolism | 2 | 100.0 |
B-Lymphocytes/metabolism | 3 | 1.0 |
DNA, Complementary/metabolism | 5 | 0.0 |
Dimerization | 7 | 0.0 |
Flow Cytometry | 5 | 0.0 |
Gene Deletion | 3 | 0.0 |
Immunoprecipitation | 2 | 0.0 |
NF-kappa B/*metabolism | 61 | 10.0 |
Recombinant Fusion Proteins/metabolism | 16 | 1.0 |
Recombinant Proteins/chemistry | 2 | 0.0 |
Transcription Factor AP-1/metabolism | 4 | 1.0 |
3T3 Cells | 5 | 0.0 |
Carrier Proteins/genetics/*metabolism | 5 | 1.0 |
Isoenzymes/metabolism | 2 | 0.0 |
Prostaglandin-Endoperoxide Synthase/metabolism | 2 | 2.0 |
RNA-Binding Proteins/metabolism | 2 | 2.0 |
*Signal Transduction/drug effects | 3 | 3.0 |
Antigens, CD/*metabolism | 15 | 2.0 |
Cysteine Endopeptidases/metabolism | 5 | 2.0 |
Receptors, Tumor Necrosis Factor/*metabolism | 38 | 18.0 |
Ubiquitin/*metabolism | 5 | 2.0 |
Antigens, CD/*physiology | 6 | 1.0 |
Antigens, CD40/genetics/metabolism/*physiology | 2 | 66.0 |
B-Lymphocytes/immunology/metabolism | 2 | 3.0 |
Mice, Inbred C57BL | 4 | 0.0 |
Proteins/genetics/metabolism/*physiology | 5 | 14.0 |
Receptors, Tumor Necrosis Factor/*physiology | 11 | 12.0 |
Amino Acid Motifs | 7 | 0.0 |
Cell Nucleus/metabolism | 3 | 0.0 |
DNA/metabolism | 2 | 0.0 |
DNA-Binding Proteins/*metabolism | 4 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 6 | 0.0 |
Immunoblotting | 8 | 0.0 |
Luciferases/metabolism | 9 | 1.0 |
Promoter Regions (Genetics) | 6 | 0.0 |
RNA, Messenger/metabolism | 5 | 0.0 |
Rats | 10 | 0.0 |
*Saccharomyces cerevisiae Proteins | 2 | 0.0 |
Transcription Factor AP-1/*metabolism | 4 | 2.0 |
Transcription, Genetic | 3 | 0.0 |
Carrier Proteins/*genetics/*metabolism | 2 | 2.0 |
DNA, Complementary/genetics | 4 | 0.0 |
Exons | 2 | 0.0 |
Ligands | 11 | 0.0 |
NF-kappa B/metabolism | 50 | 6.0 |
Phenotype | 2 | 0.0 |
Proteins/metabolism | 45 | 4.0 |
*MAP Kinase Kinase Kinase 1 | 7 | 4.0 |
Gene Expression Regulation, Neoplastic | 3 | 0.0 |
RNA, Messenger/genetics/metabolism | 6 | 0.0 |
Apoptosis/genetics | 2 | 0.0 |
Cytokines/biosynthesis | 2 | 0.0 |
Drosophila | 2 | 0.0 |
*Drosophila Proteins | 3 | 0.0 |
Proteins/genetics/*metabolism | 25 | 5.0 |
*Signal Transduction/genetics | 3 | 11.0 |
Microscopy, Fluorescence | 6 | 0.0 |
Protein Transport | 3 | 0.0 |
*Signal Transduction | 43 | 2.0 |
Precipitin Tests | 20 | 0.0 |
Proteins/chemistry/genetics/*metabolism | 8 | 9.0 |
RNA, Messenger/biosynthesis | 4 | 0.0 |
Two-Hybrid System Techniques | 8 | 0.0 |
MAP Kinase Kinase Kinases/metabolism | 3 | 9.0 |
Phosphorylation | 24 | 0.0 |
Protein-Serine-Threonine Kinases/chemistry/genetics/*metabolism | 2 | 4.0 |
Recombinant Proteins/chemistry/genetics/metabolism | 3 | 0.0 |
Blotting, Western | 21 | 0.0 |
Plasmids/genetics | 2 | 0.0 |
Viral Matrix Proteins/genetics/*physiology | 2 | 25.0 |
Cell Survival | 6 | 0.0 |
Genes, Dominant | 6 | 0.0 |
Glutathione Transferase/metabolism | 4 | 0.0 |
Mutagenesis, Site-Directed | 6 | 0.0 |
Proteins/chemistry/*metabolism | 3 | 3.0 |
Umbilical Veins/cytology | 3 | 1.0 |
Antigens, CD/chemistry/genetics/*metabolism | 3 | 10.0 |
Comparative Study | 14 | 0.0 |
Plasmids | 2 | 0.0 |
Receptors, Tumor Necrosis Factor/chemistry/genetics/*metabolism | 3 | 33.0 |
Sequence Alignment | 12 | 0.0 |
Antigens, CD40/genetics/*metabolism | 2 | 40.0 |
B-Lymphocytes/*metabolism | 5 | 2.0 |
Cell Division | 4 | 0.0 |
JNK Mitogen-Activated Protein Kinases | 37 | 6.0 |
Mitogen-Activated Protein Kinases/metabolism | 14 | 1.0 |
Receptors, IgE/metabolism | 2 | 6.0 |
TNF Receptor-Associated Factor 6 | 38 | 29.0 |
Up-Regulation | 9 | 0.0 |
p38 Mitogen-Activated Protein Kinases | 15 | 2.0 |
Alternative Splicing | 4 | 0.0 |
Enzyme Activation/drug effects | 6 | 0.0 |
*Intracellular Signaling Peptides and Proteins | 10 | 1.0 |
Mitogen-Activated Protein Kinase 1/metabolism | 2 | 0.0 |
Mitogen-Activated Protein Kinase 3 | 2 | 0.0 |
Proto-Oncogene Proteins/metabolism | 5 | 0.0 |
Evolution, Molecular | 2 | 0.0 |
*Gene Expression Regulation | 8 | 0.0 |
Mutation/genetics | 4 | 0.0 |
Sequence Analysis, DNA | 4 | 0.0 |
Interleukin-1/metabolism | 8 | 3.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/metabolism | 7 | 2.0 |
Carrier Proteins/*physiology | 5 | 2.0 |
Gene Targeting | 2 | 0.0 |
Herpesvirus 4, Human/physiology | 2 | 6.0 |
Macromolecular Substances | 11 | 0.0 |
Membrane Proteins/metabolism | 2 | 0.0 |
Mitogen-Activated Protein Kinase 8 | 6 | 7.0 |
NF-kappa B/physiology | 3 | 3.0 |
Protein Processing, Post-Translational | 2 | 0.0 |
Proteins/genetics/*physiology | 4 | 3.0 |
Structure-Activity Relationship | 7 | 0.0 |
Carrier Proteins/metabolism | 10 | 1.0 |
Caspases/metabolism | 10 | 1.0 |
Tumor Necrosis Factor-alpha/metabolism | 10 | 1.0 |
Mice, Knockout | 4 | 0.0 |
Proteins/*physiology | 12 | 6.0 |
Recombinant Proteins/metabolism | 14 | 0.0 |
Active Transport, Cell Nucleus | 3 | 1.0 |
Cell Line, Tumor | 4 | 0.0 |
I-kappa B/*metabolism | 2 | 14.0 |
Inflammation | 3 | 0.0 |
Models, Chemical | 5 | 1.0 |
Okadaic Acid/pharmacology | 2 | 2.0 |
Enzyme Inhibitors/pharmacology | 6 | 0.0 |
Kinetics | 8 | 0.0 |
Protein Biosynthesis | 12 | 0.0 |
Apoptosis/*physiology | 9 | 1.0 |
NF-kappa B/*physiology | 12 | 12.0 |
Signal Transduction/*drug effects | 4 | 1.0 |
Trans-Activation (Genetics)/drug effects | 2 | 0.0 |
Tumor Necrosis Factor-alpha/*antagonists & inhibitors/pharmacology | 2 | 7.0 |
Female | 8 | 0.0 |
In Situ Hybridization | 3 | 0.0 |
Male | 8 | 0.0 |
Proteins/*analysis | 2 | 1.0 |
Antigens, CD/metabolism | 4 | 0.0 |
Drug Synergism | 3 | 0.0 |
Protein Binding/drug effects | 5 | 1.0 |
Protein-Serine-Threonine Kinases/*metabolism | 13 | 1.0 |
Signal Transduction/drug effects | 8 | 1.0 |
Tumor Necrosis Factor-alpha/*pharmacology | 9 | 0.0 |
Protein Subunits | 4 | 1.0 |
NF-kappa B/genetics/*metabolism | 5 | 6.0 |
Oligonucleotides, Antisense/pharmacology | 2 | 0.0 |
Peptide Mapping | 4 | 0.0 |
Rabbits | 3 | 0.0 |
*JNK Mitogen-Activated Protein Kinases | 7 | 7.0 |
Mitogen-Activated Protein Kinase Kinases/metabolism | 7 | 4.0 |
*Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 12 | 48.0 |
Viral Core Proteins/genetics/*metabolism | 2 | 16.0 |
Catalysis | 2 | 0.0 |
Open Reading Frames | 2 | 0.0 |
Receptors, Tumor Necrosis Factor/*chemistry | 2 | 25.0 |
Cytosol/metabolism | 3 | 0.0 |
Caspases/*metabolism | 4 | 1.0 |
Multigene Family | 2 | 0.0 |
Proteins/*genetics | 2 | 0.0 |
*Receptors, Tumor Necrosis Factor | 3 | 7.0 |
Species Specificity | 2 | 0.0 |
Mitogen-Activated Protein Kinases/*metabolism | 11 | 2.0 |
Signal Transduction/*physiology | 15 | 1.0 |
Membrane Glycoproteins/*physiology | 3 | 1.0 |
Protein Kinases/*physiology | 2 | 3.0 |
Protein-Serine-Threonine Kinases/*physiology | 4 | 3.0 |
*Receptors, Immunologic | 3 | 1.0 |
Mitogen-Activated Protein Kinase Kinases/*metabolism | 2 | 3.0 |
Adult | 5 | 0.0 |
Aged | 3 | 0.0 |
Apoptosis/*genetics | 3 | 1.0 |
Middle Aged | 5 | 0.0 |
Apoptosis/drug effects/*physiology | 3 | 1.0 |
Cell Death/*drug effects | 2 | 6.0 |
Receptors, Tumor Necrosis Factor/genetics/metabolism | 2 | 15.0 |
Antigens, CD/physiology | 2 | 0.0 |
*Arabidopsis Proteins | 7 | 8.0 |
Protein-Serine-Threonine Kinases/physiology | 4 | 4.0 |
Receptors, Tumor Necrosis Factor/physiology | 2 | 2.0 |
Endothelium, Vascular/cytology/metabolism | 2 | 1.0 |
Fatty Acid Desaturases/physiology | 3 | 75.0 |
CHO Cells | 4 | 0.0 |
Green Fluorescent Proteins | 3 | 0.0 |
Hamsters | 4 | 0.0 |
Amino Acid Substitution | 5 | 0.0 |
Protein Structure, Secondary | 4 | 0.0 |
Fibroblasts/cytology | 2 | 0.0 |
Membrane Glycoproteins/genetics/*metabolism | 3 | 1.0 |
Mutagenesis | 3 | 0.0 |
Protein-Serine-Threonine Kinases/genetics/*metabolism | 6 | 2.0 |
Recombinant Fusion Proteins/genetics/metabolism | 3 | 0.0 |
Antigens, CD40/metabolism | 4 | 6.0 |
Peptide Fragments/metabolism | 2 | 0.0 |
Proteins/antagonists & inhibitors/*chemistry/genetics/*metabolism | 2 | 66.0 |
Surface Plasmon Resonance | 2 | 1.0 |
Sequence Deletion | 7 | 0.0 |
*Transcription Factors | 4 | 0.0 |
Protein Conformation | 6 | 0.0 |
Proteins/genetics/physiology | 2 | 3.0 |
Antigens, CD40/*metabolism | 6 | 12.0 |
Cell Membrane/metabolism | 5 | 0.0 |
Protein-Tyrosine Kinase/metabolism | 2 | 0.0 |
Biological Transport/drug effects | 2 | 0.0 |
Antigens, CD27/genetics/*metabolism | 3 | 100.0 |
Genes, Reporter/genetics | 3 | 1.0 |
Protein-Serine-Threonine Kinases/genetics/metabolism | 6 | 5.0 |
*MAP Kinase Kinase 4 | 4 | 7.0 |
Caenorhabditis elegans | 2 | 2.0 |
Protein Kinases/metabolism | 7 | 1.0 |
Receptors, Interleukin-1/metabolism | 2 | 8.0 |
Zinc Fingers | 6 | 1.0 |
Chromosome Mapping | 3 | 0.0 |
Bacterial Proteins/*metabolism | 2 | 4.0 |
Carrier Proteins/*metabolism | 11 | 1.0 |
NF-kappa B/*antagonists & inhibitors/metabolism | 3 | 13.0 |
Tetradecanoylphorbol Acetate/metabolism | 2 | 6.0 |
Carrier Proteins/*genetics/metabolism | 2 | 0.0 |
NF-kappa B/*genetics | 2 | 4.0 |
Proteins/*genetics/metabolism | 4 | 1.0 |
Signal Transduction/genetics | 2 | 0.0 |
DNA-Binding Proteins/metabolism | 6 | 0.0 |
*I-kappa B | 5 | 2.0 |
Antigens, Differentiation/metabolism | 2 | 1.0 |
Protein Kinase C/*metabolism | 2 | 0.0 |
Neoplasm Staging | 2 | 0.0 |
MAP Kinase Kinase Kinases/genetics/*metabolism | 3 | 33.0 |
Antigens, CD/*immunology | 2 | 0.0 |
Receptors, Tumor Necrosis Factor/*immunology | 2 | 10.0 |
Tumor Necrosis Factor-alpha/immunology | 2 | 1.0 |
Adolescent | 3 | 0.0 |
Protein Kinases/genetics/*metabolism | 2 | 2.0 |
Mice, Inbred BALB C | 2 | 0.0 |
NF-kappa B/metabolism/*physiology | 2 | 13.0 |
RNA Interference | 5 | 1.0 |
Ubiquitin/metabolism | 5 | 2.0 |
B-Lymphocytes/*immunology | 4 | 0.0 |
Lymphocyte Activation/immunology | 2 | 0.0 |
Antigens, CD40/*immunology | 3 | 7.0 |
CD40 Ligand | 9 | 5.0 |
Signal Transduction/immunology | 4 | 1.0 |
Viral Matrix Proteins/*metabolism | 7 | 29.0 |
Antigens, CD30/*metabolism | 3 | 37.0 |
Fluorescent Antibody Technique, Indirect | 2 | 0.0 |
RNA, Messenger/analysis | 5 | 0.0 |
Membrane Glycoproteins/metabolism | 5 | 0.0 |
*Proteins | 4 | 0.0 |
*Cell Transformation, Viral | 3 | 1.0 |
Herpesvirus 4, Human/*genetics | 2 | 2.0 |
*Homeodomain Proteins | 2 | 0.0 |
Viral Matrix Proteins/*genetics/metabolism | 2 | 50.0 |
Proteins/metabolism/*physiology | 6 | 13.0 |
Tumor Necrosis Factor-alpha/chemistry/metabolism | 2 | 100.0 |
Recombinant Proteins/chemistry/metabolism | 2 | 0.0 |
Consensus Sequence | 3 | 0.0 |
Peptide Fragments/chemistry/metabolism | 4 | 3.0 |
Lymphocytes/*metabolism | 2 | 1.0 |
T-Lymphocytes/metabolism | 2 | 0.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/*metabolism | 14 | 4.0 |
Enzyme Activation/genetics/immunology | 2 | 10.0 |
*Mitogen-Activated Protein Kinases | 24 | 6.0 |
Protein-Serine-Threonine Kinases/biosynthesis/chemistry/*metabolism | 2 | 66.0 |
Receptors, Tumor Necrosis Factor/genetics/*physiology | 3 | 16.0 |
Binding, Competitive | 3 | 0.0 |
Carrier Proteins/chemistry/*metabolism | 2 | 2.0 |
NF-kappa B/antagonists & inhibitors/*metabolism | 3 | 5.0 |
Yeasts/genetics | 2 | 2.0 |
Lymphocyte Activation | 3 | 0.0 |
Transfection/immunology | 3 | 6.0 |
Antigens, Viral/*metabolism | 2 | 20.0 |
Transcription Factors/metabolism | 4 | 0.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/*physiology | 2 | 8.0 |
Chimeric Proteins | 2 | 2.0 |
Interleukin-1/physiology | 2 | 2.0 |
Protein Binding/physiology | 2 | 0.0 |
Tumor Necrosis Factor-alpha/physiology | 3 | 1.0 |
Antigens, CD40/*physiology | 4 | 11.0 |
DNA Mutational Analysis | 2 | 0.0 |
Membrane Glycoproteins/physiology | 2 | 1.0 |
Oncogene Proteins, Viral/*metabolism | 2 | 5.0 |
Biological Transport | 3 | 0.0 |
Cell Division/immunology | 2 | 0.0 |
Enzyme Activation/immunology | 2 | 1.0 |
Antigens, CD40/genetics/*physiology | 4 | 40.0 |
Binding Sites/immunology | 2 | 3.0 |
COS Cells | 6 | 0.0 |
Recombination, Genetic | 2 | 0.0 |
Antigens, CD40/chemistry/*metabolism | 2 | 100.0 |
Cytoplasm/chemistry | 2 | 1.0 |
*Mitogen-Activated Protein Kinase Kinases | 2 | 2.0 |
*Carrier Proteins | 3 | 0.0 |
*Membrane Glycoproteins | 2 | 0.0 |
Lymphoma, B-Cell | 2 | 5.0 |
*Trans-Activation (Genetics) | 2 | 0.0 |
Receptor Aggregation | 2 | 2.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/genetics/*metabolism | 2 | 9.0 |
Cell Line, Transformed | 6 | 0.0 |
Viral Matrix Proteins/genetics/*metabolism | 2 | 10.0 |
Recombinant Proteins/genetics/metabolism | 5 | 0.0 |
*Antigens, CD | 2 | 0.0 |
Plant Proteins/physiology | 2 | 50.0 |
MAP Kinase Kinase Kinases | 2 | 20.0 |
Ceramides/pharmacology | 2 | 6.0 |
*Gene Expression Regulation, Viral | 2 | 0.0 |
Herpesvirus 4, Human/*metabolism | 4 | 9.0 |
*Caspases | 4 | 7.0 |
Mitochondria/metabolism | 2 | 0.0 |
Mitochondrial Proteins/metabolism | 2 | 10.0 |
Recombinant Fusion Proteins/biosynthesis/metabolism | 3 | 3.0 |
Binding Sites/genetics | 6 | 0.0 |
Genetic Vectors | 4 | 0.0 |
In Vitro | 3 | 0.0 |
Reticulocytes/metabolism | 2 | 2.0 |
Enzyme Activation/physiology | 2 | 1.0 |
Sequence Deletion/genetics | 2 | 1.0 |
Transfection/genetics | 5 | 3.0 |
Ubiquitin-Protein Ligases/metabolism | 2 | 4.0 |
Umbilical Veins | 2 | 0.0 |
Sphingomyelin Phosphodiesterase/*metabolism | 2 | 11.0 |
RNA, Small Interfering/metabolism | 4 | 2.0 |
Serpins/metabolism | 2 | 12.0 |
Viral Proteins/metabolism | 2 | 2.0 |
DNA, Complementary/analysis | 2 | 0.0 |
*Gene Expression Regulation, Neoplastic | 3 | 0.0 |
Polymerase Chain Reaction | 4 | 0.0 |
*Viral Proteins | 2 | 1.0 |
Cell Survival/drug effects | 2 | 0.0 |
Trans-Activators/metabolism | 2 | 0.0 |
Receptors, Nerve Growth Factor/genetics/*metabolism | 2 | 12.0 |
Enzyme Induction | 2 | 0.0 |
B-Lymphocytes/*immunology/metabolism | 2 | 4.0 |
Tumor Necrosis Factor-alpha/metabolism/*pharmacology | 2 | 3.0 |
*Zinc Fingers | 2 | 0.0 |
Receptors, Tumor Necrosis Factor/metabolism/*physiology | 3 | 37.0 |
Antigens, CD95/*physiology | 2 | 2.0 |
Recombinant Fusion Proteins | 2 | 0.0 |
Saccharomyces cerevisiae | 2 | 0.0 |
Antigens, CD30/genetics/*metabolism | 2 | 100.0 |
Conserved Sequence | 3 | 0.0 |
Neovascularization, Pathologic | 2 | 0.0 |
*Up-Regulation | 2 | 0.0 |
Carrier Proteins/genetics | 2 | 0.0 |
Child | 2 | 0.0 |
Child, Preschool | 2 | 0.0 |
Chimeric Proteins/metabolism | 2 | 1.0 |
Gene Expression | 5 | 0.0 |
Luciferases/genetics | 3 | 0.0 |
Saccharomyces cerevisiae/genetics | 3 | 0.0 |
Dactinomycin/pharmacology | 3 | 0.0 |
TNF Receptor-Associated Factor 2/metabolism | 2 | 100.0 |
NF-kappa B/genetics | 2 | 5.0 |
DNA, Complementary | 3 | 0.0 |
Organ Specificity | 3 | 0.0 |
Caspase 1 | 2 | 5.0 |
Viral Matrix Proteins/*physiology | 2 | 18.0 |
NF-kappa B/*antagonists & inhibitors | 2 | 4.0 |
Drosophila/genetics | 2 | 1.0 |
Antineoplastic Agents/*pharmacology | 2 | 0.0 |
Down-Regulation | 3 | 0.0 |
Nuclear Proteins/metabolism | 3 | 0.0 |
MAP Kinase Signaling System | 2 | 0.0 |
Nuclear Pore Complex Proteins/metabolism | 2 | 20.0 |
Apoptosis/physiology | 3 | 0.0 |
Interleukin-1/pharmacology | 2 | 0.0 |
Proteins/genetics | 2 | 0.0 |
Antigens, CD40 | 3 | 5.0 |
Antigens, Differentiation, B-Lymphocyte/*metabolism | 2 | 5.0 |
Colonic Neoplasms | 2 | 1.0 |
Intercellular Adhesion Molecule-1/metabolism | 2 | 1.0 |
Genetic Vectors/genetics | 2 | 0.0 |
Luminescent Proteins/genetics | 2 | 1.0 |
Glycoproteins/*metabolism | 2 | 1.0 |
Membrane Microdomains/*metabolism | 2 | 4.0 |
Receptors, Cytoplasmic and Nuclear/*metabolism | 2 | 1.0 |
Antigens, CD40/*biosynthesis | 2 | 15.0 |
RNA, Small Interfering/genetics/metabolism | 2 | 4.0 |
Antigens, CD95/metabolism | 2 | 1.0 |
Cycloheximide/pharmacology | 2 | 0.0 |
Fatty Acid Desaturases/metabolism | 2 | 5.0 |
Adenoviridae/genetics | 2 | 0.0 |
Spectrum Analysis, Mass | 2 | 0.0 |
